Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SABS, SABSW | SAB Biotherapeutics, Inc. | Chief Medical Officer | $242K | Feb 21, 2024 | ||
IBIO | iBio, Inc. | Director | Nov 21, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|